Skip to main content
Clinical Trials/NCT04578418
NCT04578418Active, not recruitingNot Applicable

Effect of Collagen Supplementation on Tendinopathy in Elite Athletes

Bispebjerg Hospital2 sites in 1 country64 target enrollmentStarted: September 16, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
64
Locations
2
Primary Endpoint
Maximal tendon pain during the past week at preferred sporting activity

Study Overview

Brief Summary

Tendon injuries represent a significant problem in elite athletes. Therefore, prevention and effective treatment of tendon overload injury/tendinopathy is important. Among different treatment options, heavy-slow loading based rehabilitation is considered among the most efficient treatments in athletes. In this study, we will investigate if supplementation with hydrolyzed collagen in combination with a heavy-slow loading based 12 weeks rehabilitation regime can improve treatment of tendon overload injury/tendinopathy. The investigators will examine elite athletes with overload injury/tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography), and vascularization (Doppler US). The investigators hypothesize that collagen supplementation can have an improving effect on tendon pain and function. Thus, the investigation will show if a rehabilitation regime of collagen supplementation combined with heavy-slow mechanical loading can improve tendon healing compared to mechanical loading alone.

Detailed Description

Randomized placebo-controlled intervention study with follow-up after one month

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Elite athletes
  • 18-40 years old
  • Exercise related tendon pain on one or both legs
  • Soreness during physical examination of tendon upon palpation
  • Uni- or bilateral tendinopathy symptoms > 3 months

Exclusion Criteria

  • Previous tendon surgery
  • Arthritis
  • Corticosteroid injection for tendinopathy within the last 3 months
  • Any form of tendon injection within the last 3 months

Outcomes

Primary Outcomes

Maximal tendon pain during the past week at preferred sporting activity

Time Frame: Baseline-12 weeks

Change from baseline - 12 weeks using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)

Secondary Outcomes

  • Maximal tendon pain during the past week at preferred sporting activity(Baseline, 6 weeks + 6 month follow-up)
  • Self-reported activity level of sporting activities (hours/week)(Baseline, 6 and 12 weeks + 6 month follow-up)
  • Single-leg decline squat (SLDS) test(Baseline - 12 weeks)
  • Jump test(Baseline - 12 weeks)
  • Treatment satisfaction(12 weeks)
  • Collagen supplement(Baseline - 12 weeks + 6 month follow-up)
  • Adverse events (e.g. allergies, gastro-intestinal side effects) related to supplement ingestion(Baseline - 12 weeks + 6 month follow-up)
  • Return-to-sport activities(Baseline - 12 weeks + 6 month follow-up)
  • Change from baseline Victorian Institute of Sports Assessment - Patella/Achilles Questionnaire (VISA-P/A) at 12 wks(Baseline, 6 and 12 weeks + 6 month follow-up)
  • Change from baseline Foot function index - Plantaris questionnaire at 12 wks(Baseline, 6 and 12 weeks + 6 month follow-up)
  • Tendon Doppler activity using Ultrasonography power Doppler(Baseline - 12 weeks)
  • Tendon thickness measured using Ultrasonography(Baseline - 12 weeks)
  • Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.(Baseline, 6 and 12 weeks + 6 month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christian Couppé

Principal Investigator

Bispebjerg Hospital

Study Sites (2)

Loading locations...

Similar Trials